Turning Point Therapeutics, Inc. Operating Income
Turning Point Therapeutics, Inc. reported Operating Income of -$124.36 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-08-08
- Turning Point Therapeutics, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$124.36M.
- Turning Point Therapeutics, Inc. operating income (loss) for the quarter ending 2022-03-31 was -$74.94M.
- Turning Point Therapeutics, Inc. operating income (loss) for the quarter ending 2021-12-31 was -$78.64M.
- Turning Point Therapeutics, Inc. operating income (loss) for the quarter ending 2021-09-30 was -$66.65M.
- Turning Point Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$238.00M.
- Turning Point Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$161.84M.
- Turning Point Therapeutics, Inc. operating income (loss) for fiscal 2019 was -$77.72M.
- Turning Point Therapeutics, Inc. operating income (loss) for fiscal 2018 was -$25.64M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | -$124.36M 10-Q · filed 2022-08-08 | -$199.30M 10-Q · filed 2022-08-08 | -$277.94M derived: sum of 3 quarters · filed 2022-08-08 | -$344.59M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2022-03-31 | -$74.94M 10-Q · filed 2022-05-10 | -$153.58M derived: sum of 2 quarters · filed 2022-05-10 | -$220.23M derived: sum of 3 quarters · filed 2022-05-10 | -$276.89M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-12-31 | -$78.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$145.29M derived: sum of 2 quarters · filed 2022-02-28 | -$201.95M derived: sum of 3 quarters · filed 2022-08-08 | -$238.00M 10-K · filed 2022-02-28 | |
| 2021-09-30 | -$66.65M 10-Q · filed 2021-11-09 | -$123.31M derived: sum of 2 quarters · filed 2022-08-08 | -$159.36M 10-Q · filed 2021-11-09 | -$207.30M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-06-30 | -$56.66M 10-Q · filed 2022-08-08 | -$92.71M 10-Q · filed 2022-08-08 | -$140.65M derived: sum of 3 quarters · filed 2022-08-08 | -$159.18M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | -$36.05M 10-Q · filed 2022-05-10 | -$83.99M derived: sum of 2 quarters · filed 2022-05-10 | -$102.53M derived: sum of 3 quarters · filed 2022-05-10 | -$135.26M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$47.94M 10-K · filed 2021-03-01 | -$66.48M derived: sum of 2 quarters · filed 2021-11-09 | -$99.21M derived: sum of 3 quarters · filed 2021-11-09 | -$161.84M 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$18.54M 10-Q · filed 2021-11-09 | -$51.27M derived: sum of 2 quarters · filed 2021-11-09 | -$113.90M 10-Q · filed 2021-11-09 | -$136.96M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | -$32.73M 10-Q · filed 2021-08-09 | -$95.36M 10-Q · filed 2021-08-09 | -$118.42M derived: sum of 3 quarters · filed 2021-08-09 | -$140.56M derived: sum of 4 quarters · filed 2021-08-09 | |
| 2020-03-31 | -$62.63M 10-Q · filed 2021-05-05 | -$85.69M derived: sum of 2 quarters · filed 2021-05-05 | -$107.83M derived: sum of 3 quarters · filed 2021-05-05 | -$126.28M derived: sum of 4 quarters · filed 2021-05-05 | |
| 2019-12-31 | -$23.07M 10-K · filed 2021-03-01 | -$45.20M derived: sum of 2 quarters · filed 2021-03-01 | -$63.66M derived: sum of 3 quarters · filed 2021-03-01 | -$77.72M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$22.14M 10-K · filed 2021-03-01 | -$40.59M derived: sum of 2 quarters · filed 2021-03-01 | -$54.66M 10-Q · filed 2020-11-12 | -$64.14M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$18.45M 10-K · filed 2021-03-01 | -$32.52M 10-Q · filed 2020-08-10 | -$42.00M derived: sum of 3 quarters · filed 2021-03-01 | -$48.13M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$14.06M 10-K · filed 2021-03-01 | -$14.06M 10-Q · filed 2019-05-31 | -$23.54M derived: sum of 2 quarters · filed 2021-03-01 | -$29.67M derived: sum of 3 quarters · filed 2021-03-01 | -$34.84M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$9.48M 10-K · filed 2020-03-18 | -$15.61M derived: sum of 2 quarters · filed 2020-03-18 | -$20.78M derived: sum of 3 quarters · filed 2020-03-18 | -$25.64M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$6.13M 10-K · filed 2020-03-18 | -$11.30M derived: sum of 2 quarters · filed 2020-03-18 | -$16.16M 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | -$5.17M 10-K · filed 2020-03-18 | -$10.03M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | -$4.86M 10-K · filed 2020-03-18 | ||||
| 2017-12-31 | -$16.73M 10-K · filed 2020-03-18 |